Carisoprodol Use and Safety Guidelines

Introduction to Carisoprodol

Carisoprodol is a centrally acting muscle relaxant with barbiturate-like properties, central nervous system depressant effects, anxiolytic properties, rapid onset of action, and effects lasting 4-6 hours, and it should only be used for short periods (up to 2-3 weeks) for acute, painful musculoskeletal conditions 1

Carisoprodol has numerous concerning adverse effects, including sedation, seizures, drug dependence and withdrawal, tachycardia, postural hypotension, and central nervous system depression, particularly when combined with other CNS depressants 1, 2
The American College of Physicians and other medical societies recommend being cautious of carisoprodol's significant abuse potential, classified as a controlled substance due to abuse and addiction risk, with the FDA reporting escalating abuse in the past decade 1

Prolonged use of carisoprodol at high doses leads to tolerance, dependence, and withdrawal symptoms, and withdrawal can cause severe symptoms, necessitating a slow taper over 4-9 days rather than abrupt cessation 1
For patients on carisoprodol requiring surgery, it is recommended to hold the medication on the day of operation and consider tapering off or switching to an alternative agent before surgical procedures, while avoiding co-prescription with opioids and benzodiazepines due to increased mortality risk 1, 2

For musculoskeletal pain, consider alternative therapies with better safety profiles, such as NSAIDs as first-line therapy, other skeletal muscle relaxants with lower abuse potential, and non-pharmacological approaches like exercise therapy and mindfulness-based stress reduction, as recommended by various medical guidelines 4

Systematic reviews indicate limited evidence for the long-term effectiveness of carisoprodol, highlighting the need for cautious prescribing practices and consideration of alternative therapies 3